The Prostate Cancer Foundation is a nonprofit group that funds and promotes research into prostate cancer. Its filings show it lobbied in 2026 on veterans’ health issues, specifically supporting S.4993 (the POPCaP Act of 2026) and a House companion bill to create a precision oncology program for prostate cancer and related Veterans Affairs policies. It hired the firm Brownstein Hyatt Farber Schreck to do this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN LUCIO
The latest disclosures for this client.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
BROWNSTEIN HYATT FARBER SCHRECK, LLP
JONATHAN TOWERS
BROWNSTEIN HYATT FARBER SCHRECK, LLP
NORMAN BROWNSTEIN
BROWNSTEIN HYATT FARBER SCHRECK, LLP